From Wikipedia, the free encyclopedia
MBL deficiency
Other namesMannose-binding lectin deficiency
Structure of the MBL2 protein.
Specialty Immunology

MBL deficiency or mannose-binding lectin deficiency is an illness that has an impact on immunity. Low levels of mannose-binding lectin, an immune system protein, are present in the blood of those who have this illness. It's unclear if this deficiency increases the risk of recurrent infections in those who are affected. [1]

Signs and symptoms

Specific infection susceptibility has been linked to low MBL levels. [2] This is especially true when it comes to chronic illnesses like cystic fibrosis, chemotherapy-induced neutropenia, and weakened immunity, which are all present in the neonatal period. [3] Moreover, septic shock and death have been connected to MBL deficiency. [4]

Causes

Mannose-binding lectin deficiency can result from mutations in the MBL2 gene. [1]

Mechanism

Mannose-binding lectin (MBL) is a soluble innate immune system pattern recognition molecule. [5] MBL activates the complement lectin pathway by binding to glycoconjugates on the surface of a variety of clinically significant bacteria, viruses, and fungi that contain mannose, fucose, or N-acetylglucosamine. [6] [7] MBL stimulates leucocyte chemotaxis and activation as well as phagocytosis through complement activation. [8] [9] Additionally, MBL may contribute to the resolution of lung inflammation by apoptosis cell clearance and proinflammatory cytokine secretion suppression. [10] [11]

Epidemiology

Depending on the definition of deficiency, MBL deficiency affects 10–30% of individuals, making it one of the most prevalent immune defects. [12]

References

  1. ^ a b "Mannose-binding lectin deficiency: MedlinePlus Genetics". MedlinePlus. May 1, 2018. Retrieved January 22, 2024.
  2. ^ Haibrich, Michelle; Ben-Shoshan, Moshe; Mccusker, Christine (2012). "Mannose Binding Lectin Deficiency: More than Meets the Eye". Clinical Medicine Insights: Pediatrics. 6. SAGE Publications: 89–94. doi: 10.4137/cmped.s9860. ISSN  1179-5565. PMC  3620812. PMID  23641170.
  3. ^ Eddie Ip, W. K.; Takahashi, Kazue; Alan Ezekowitz, R.; Stuart, Lynda M. (June 29, 2009). "Mannose-binding lectin and innate immunity". Immunological Reviews. 230 (1). Wiley: 9–21. doi: 10.1111/j.1600-065x.2009.00789.x. ISSN  0105-2896. PMID  19594626. S2CID  44299051.
  4. ^ Dommett, R. M.; Klein, N; Turner, M. W. (2006). "Mannose-binding lectin in innate immunity: past, present and future". Tissue Antigens. 68 (3). Wiley: 193–209. doi: 10.1111/j.1399-0039.2006.00649.x. ISSN  0001-2815. PMC  7169806.
  5. ^ Kilpatrick, D (September 19, 2002). "Mannan-binding lectin: clinical significance and applications". Biochimica et Biophysica Acta (BBA) - General Subjects. 1572 (2–3). Elsevier BV: 401–413. doi: 10.1016/s0304-4165(02)00321-5. ISSN  0304-4165. PMID  12223282.
  6. ^ Neth, Olaf; Jack, Dominic L.; Dodds, Alister W.; Holzel, Helen; Klein, Nigel J.; Turner, Malcolm W. (2000). "Mannose-Binding Lectin Binds to a Range of Clinically Relevant Microorganisms and Promotes Complement Deposition". Infection and Immunity. 68 (2). American Society for Microbiology: 688–693. doi: 10.1128/iai.68.2.688-693.2000. ISSN  0019-9567. PMC  97193. PMID  10639434.
  7. ^ Møller-Kristensen, Mette; Ip, W. K. Eddie; Shi, Lei; Gowda, Lakshmi D.; Hamblin, Michael R.; Thiel, Steffen; Jensenius, Jens Chr.; Ezekowitz, R. Alan B.; Takahashi, Kazue (February 1, 2006). "Deficiency of Mannose-Binding Lectin Greatly Increases Susceptibility to Postburn Infection with Pseudomonas aeruginosa". The Journal of Immunology. 176 (3). The American Association of Immunologists: 1769–1775. doi: 10.4049/jimmunol.176.3.1769. ISSN  0022-1767. PMC  3071691. PMID  16424207.
  8. ^ Thiel, Steffen; Vorup-Jensen, Thomas; Stover, Cordula M.; Schwaeble, Wilhelm; Laursen, Steen B.; Poulsen, Knud; Willis, Anthony C.; Eggleton, Paul; Hansen, Søren; Holmskov, Uffe; Reid, Kenneth B. M.; Jensenius, Jens C. (1997). "A second serine protease associated with mannan-binding lectin that activates complement". Nature. 386 (6624). Springer Science and Business Media LLC: 506–510. Bibcode: 1997Natur.386..506T. doi: 10.1038/386506a0. ISSN  0028-0836. PMID  9087411.
  9. ^ Wallis, Russell (2007). "Interactions between mannose-binding lectin and MASPs during complement activation by the lectin pathway". Immunobiology. 212 (4–5). Elsevier BV: 289–299. doi: 10.1016/j.imbio.2006.11.004. hdl: 2381/15008. ISSN  0171-2985. PMID  17544814.
  10. ^ Hodge, Sandra; Matthews, Geoffrey; Dean, Melinda M.; Ahern, Jessica; Djukic, Michael; Hodge, Greg; Jersmann, Hubertus; Holmes, Mark; Reynolds, Paul N. (2010). "Therapeutic Role for Mannose-Binding Lectin in Cigarette Smoke–Induced Lung Inflammation?". American Journal of Respiratory Cell and Molecular Biology. 42 (2). American Thoracic Society: 235–242. doi: 10.1165/rcmb.2008-0486oc. ISSN  1044-1549. PMID  19411612.
  11. ^ Wang, Mingyong; Chen, Yue; Zhang, Yani; Zhang, Liyun; Lu, Xiao; Chen, Zhengliang (March 7, 2011). "Mannan-binding lectin directly interacts with Toll-like receptor 4 and suppresses lipopolysaccharide-induced inflammatory cytokine secretion from THP-1 cells". Cellular & Molecular Immunology. 8 (3). Springer Science and Business Media LLC: 265–275. doi: 10.1038/cmi.2011.1. ISSN  1672-7681. PMC  4012877. PMID  21383675.
  12. ^ Eisen, Damon P. (July 7, 2009). "Mannose-Binding Lectin Deficiency and Respiratory Tract Infection". Journal of Innate Immunity. 2 (2). S. Karger AG: 114–122. doi: 10.1159/000228159. ISSN  1662-811X. PMC  7179718. PMID  20375630.

Further reading

External links